Close Menu

In Nature this week, Peter Fiske writes that too many young scientists put themselves at a disadvantage by adopting a passive voice both in their writing, and in their career development initiatives. Though science publishing has traditionally favored the passive voice — "10 µL of buffer was added," rather than "we added 10 µL of buffer" — Fiske writes that more young scientists have begun to employ a more active tone in their manuscripts.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Bloomberg reports AstraZeneca may conduct another study of its candidate SARS-CoV-2 vaccine after dosing error.

Moderna is applying for an Emergency Use Authorization for its coronavirus vaccine, according to the New York Times.

The National Health Service is to conduct a trial of Grail's blood-based screening test for cancer.

In PLOS this week: somatic mutation patterns of glioblastomas among Lebanese patients, phenome-wide study using UK Biobank data, and more.